Investing.com - Zai Lab (NASDAQ:ZLAB) reported on Monday first quarter earnings that missed analysts' forecasts and revenue that topped expectations.
Zai Lab announced earnings per share of $-2.64 on revenue of $20.1M. Analysts polled by Investing.com anticipated EPS of $-0.9313 on revenue of $17.65M.
Zai Lab shares are up 16.85% from the beginning of the year, still down 18.29% from its 52 week high of $193.54 set on January 20. They are outperforming the Nasdaq which is up 6.7% from the start of the year.
Zai Lab follows other major Healthcare sector earnings this month
Zai Lab's report follows an earnings beat by J&J on April 20, who reported EPS of $2.59 on revenue of $22.32B, compared to forecasts EPS of $2.34 on revenue of $21.98B.
Pfizer had beat expectations on May 4 with first quarter EPS of $0.93 on revenue of $14.58B, compared to forecast for EPS of $0.7759 on revenue of $13.65B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar